Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Current Deferred Revenue: 2013-2025

Historic Current Deferred Revenue for Mesa Laboratories (MLAB) over the last 12 years, with Sep 2025 value amounting to $14.3 million.

  • Mesa Laboratories' Current Deferred Revenue fell 1.73% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 1.73%. This contributed to the annual value of $14.8 million for FY2025, which is 5.63% down from last year.
  • According to the latest figures from Q3 2025, Mesa Laboratories' Current Deferred Revenue is $14.3 million, which was down 5.42% from $15.1 million recorded in Q2 2025.
  • In the past 5 years, Mesa Laboratories' Current Deferred Revenue registered a high of $16.3 million during Q3 2022, and its lowest value of $9.0 million during Q1 2021.
  • For the 3-year period, Mesa Laboratories' Current Deferred Revenue averaged around $15.0 million, with its median value being $14.8 million (2024).
  • Per our database at Business Quant, Mesa Laboratories' Current Deferred Revenue skyrocketed by 71.10% in 2021 and then fell by 10.04% in 2023.
  • Quarterly analysis of 5 years shows Mesa Laboratories' Current Deferred Revenue stood at $13.8 million in 2021, then grew by 17.56% to $16.2 million in 2022, then dropped by 9.33% to $14.7 million in 2023, then fell by 0.05% to $14.7 million in 2024, then declined by 1.73% to $14.3 million in 2025.
  • Its last three reported values are $14.3 million in Q3 2025, $15.1 million for Q2 2025, and $14.8 million during Q1 2025.